Biosimilars in oncology: Effects on economy and therapeutic innovations.
Sign Up to like & getrecommendations! Published in 2020 at "European journal of cancer"
DOI: 10.1016/j.ejca.2020.07.037
Abstract: AIM The introduction of new and innovative treatment options for cancer patients is accompanied by a tremendous increase in healthcare costs. Consequently, new financing approaches are strongly needed to reduce the burden on the healthcare… read more here.
Keywords: healthcare; biosimilars oncology; mio eur; healthcare system ... See more keywords